Neuroscience
On the New York Times website:
Earlier diagnosis giving Alzheimer's a new voice
By THE ASSOCIATED PRESS
Published: June 2, 2008
Filed at 4:26 p.m. ET
"WASHINGTON (AP) -- Don Hayen has a handy way of deflecting the instant pity that comes when he reveals his Alzheimer's disease: "But I haven't lost my keys all day," he quickly jokes. Hayen is part of a growing new movement in Alzheimer's: Patients diagnosed early enough to still be articulate and demand better care and better research.
They are giving a voice to a disease whose victims until now have remained largely silent, and powerless.
It's a shift with big ramifications."
[ ... Read the full article ... ]
- Links For World Alzheimer's Day
Today, September 21, is World Alzheimer's Day and to mark the date Alzheimer's Disease International has published a new report on combating the stigma of Alzheimer's Disease. And to join in the day's events I've collected together...
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By GINA KOLATA The New York Times Published: January 20, 2011 "A committee voted that the agency should approve the first test that can show the characteristic...
- Alzheimer's Disease (ad): Dementia Telephone Screening
Tomorrow's Sunday New York Times Magazine is its annual new ideas of the past year issue. Among the many shiny ideas presented is telephone screening for dementia: Alzheimer’s Telephone Screening By RON FEEMSTER The New York Times Published: December...
- Reminyl (galantamine Hydrobromide)
From the New York Times: Johnson & Johnson Reports Reminyl Deaths By THE ASSOCIATED PRESS Published: January 21, 2005 Filed at 5:08 p.m. ET RARITAN, N.J. (AP) -- Patients taking Alzheimer's drug Reminyl in a test for another use had higher...
- Medicare To Cover Pet In Diagnosis Of Some Suspected Dementias
Medicare has announced that it will begin authorizing coverage for obtaining PET scans to aid in diagnosis for patients with atypical symptoms of Alzheimer's disease or those suspected of rarer dementing diseases, such as the "fronto-temporal" dementias. ...
Neuroscience
Alzheimer's Disease
On the New York Times website:
Earlier diagnosis giving Alzheimer's a new voice
By THE ASSOCIATED PRESS
Published: June 2, 2008
Filed at 4:26 p.m. ET
"WASHINGTON (AP) -- Don Hayen has a handy way of deflecting the instant pity that comes when he reveals his Alzheimer's disease: "But I haven't lost my keys all day," he quickly jokes. Hayen is part of a growing new movement in Alzheimer's: Patients diagnosed early enough to still be articulate and demand better care and better research.
They are giving a voice to a disease whose victims until now have remained largely silent, and powerless.
It's a shift with big ramifications."
[ ... Read the full article ... ]
- Links For World Alzheimer's Day
Today, September 21, is World Alzheimer's Day and to mark the date Alzheimer's Disease International has published a new report on combating the stigma of Alzheimer's Disease. And to join in the day's events I've collected together...
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By GINA KOLATA The New York Times Published: January 20, 2011 "A committee voted that the agency should approve the first test that can show the characteristic...
- Alzheimer's Disease (ad): Dementia Telephone Screening
Tomorrow's Sunday New York Times Magazine is its annual new ideas of the past year issue. Among the many shiny ideas presented is telephone screening for dementia: Alzheimer’s Telephone Screening By RON FEEMSTER The New York Times Published: December...
- Reminyl (galantamine Hydrobromide)
From the New York Times: Johnson & Johnson Reports Reminyl Deaths By THE ASSOCIATED PRESS Published: January 21, 2005 Filed at 5:08 p.m. ET RARITAN, N.J. (AP) -- Patients taking Alzheimer's drug Reminyl in a test for another use had higher...
- Medicare To Cover Pet In Diagnosis Of Some Suspected Dementias
Medicare has announced that it will begin authorizing coverage for obtaining PET scans to aid in diagnosis for patients with atypical symptoms of Alzheimer's disease or those suspected of rarer dementing diseases, such as the "fronto-temporal" dementias. ...